Publications
Detailed Information
Cefotetan versus Conventional Triple Antibiotic Prophylaxis in Elective Colorectal Cancer Surgery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Woon Kyung | - |
dc.contributor.author | Park, Ji Won | - |
dc.contributor.author | Lim, Seok-Byung | - |
dc.contributor.author | Choi, Hyo Seong | - |
dc.contributor.author | Jeong, Seung-Yong | - |
dc.date.accessioned | 2012-06-29T06:30:59Z | - |
dc.date.available | 2012-06-29T06:30:59Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.citation | JOURNAL OF KOREAN MEDICAL SCIENCE; Vol.25 3; 429-434 | ko_KR |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77961 | - |
dc.description.abstract | This study examined infectious outcomes in elective colorectal cancer surgery between cefotetan alone or conventional triple antibiotics. From January to December 2007, 461 consecutive primary colorectal cancer patients underwent elective surgery. Group A contained 225 patients who received conventional triple antibiotics (cephalosporin, aminoglycoside and metronidazole) for prophylaxis, and group B contained 236 patients who received cefotetan alone for prophylaxis. Treatment failure was defined as the presence of postoperative infection including surgical-site infection (SSI), anastomotic leakage, and pneumonia or urinary tract infection. The two groups were similar in terms of demographics, American Society of Anesthesiologists (ASA) score, tumour location, stage, surgical approach (conventional open vs. laparoscopy-assisted), and type of operation. The treatment failure rates were 3.1% in Group A and 3.4% in Group B (absolute difference,-0.3%; 95% confidence interval [CI], 0.39 to 3.07, P=0.866), with SSI being the most common reason for failure in both groups (2.7% in Group A and 3.0% in Group B [absolute difference,-0.3%; 95% CI, 0.37 to 3.37, P=0.846]). Cefotetan alone is as effective as triple antibiotics for prophylaxis in primary colorectal cancer patients undergoing elective surgery. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | ko_KR |
dc.subject | Antibiotic Prophylaxis | ko_KR |
dc.subject | Cefotetan | ko_KR |
dc.subject | Colorectal Neoplasms | ko_KR |
dc.subject | Surgical Wound Infection | ko_KR |
dc.title | Cefotetan versus Conventional Triple Antibiotic Prophylaxis in Elective Colorectal Cancer Surgery | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정운경 | - |
dc.contributor.AlternativeAuthor | 박지원 | - |
dc.contributor.AlternativeAuthor | 임석병 | - |
dc.contributor.AlternativeAuthor | 최효성 | - |
dc.contributor.AlternativeAuthor | 정승용 | - |
dc.identifier.doi | 10.3346/jkms.2010.25.3.429 | - |
dc.citation.journaltitle | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.description.citedreference | Welsch T, 2007, INT J COLORECTAL DIS, V22, P1499, DOI 10.1007/s00384-007-0354-3 | - |
dc.description.citedreference | Blumetti J, 2007, SURGERY, V142, P704, DOI 10.1016/j.surg.2007.05.012 | - |
dc.description.citedreference | Itani KMF, 2006, NEW ENGL J MED, V355, P2640 | - |
dc.description.citedreference | Falagas ME, 2006, LANCET INFECT DIS, V6, P438 | - |
dc.description.citedreference | Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174 | - |
dc.description.citedreference | SHPITZ B, 2005, SURG INFECT LARCHMT, V6, P305 | - |
dc.description.citedreference | AOUN E, 2005, INT J SURG, V3, P69 | - |
dc.description.citedreference | Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99 | - |
dc.description.citedreference | Paul M, 2004, BRIT MED J, V328, P668 | - |
dc.description.citedreference | Zmora O, 2003, AM SURGEON, V69, P150 | - |
dc.description.citedreference | KENDLER JS, 2003, INFECT DIS, P1773 | - |
dc.description.citedreference | Braga M, 2002, ANN SURG, V236, P759, DOI 10.1097/01.SLA.0000036269.60340.AE | - |
dc.description.citedreference | Melling AC, 2001, LANCET, V358, P876 | - |
dc.description.citedreference | Takahashi J, 2001, SPINE, V26, P1698 | - |
dc.description.citedreference | Song F, 1998, BRIT J SURG, V85, P1232 | - |
dc.description.citedreference | KEELING NJ, 1995, ANN ROY COLL SURG, V77, P245 | - |
dc.description.citedreference | ARNAUD JP, 1992, J HOSP INFECT, V22, P23 | - |
dc.description.citedreference | HORAN TC, 1992, AM J INFECT CONTROL, V20, P271 | - |
dc.description.citedreference | SKIPPER D, 1992, J HOSP INFECT, V21, P73 | - |
dc.description.citedreference | OHZATO H, 1992, SURGERY, V111, P201 | - |
dc.description.citedreference | PULLICINO EA, 1990, LYMPHOKINE RES, V9, P231 | - |
dc.description.citedreference | PERITI P, 1989, DIS COLON RECTUM, V32, P121 | - |
dc.description.citedreference | QUINTILIANI R, 1988, AM J SURG, V155, P67 | - |
dc.description.citedreference | BELLANTONE R, 1988, DRUG EXP CLIN RES, V14, P763 | - |
dc.description.citedreference | ARONSEN KF, 1972, SCAND J CLIN LAB I S, V124, P127 | - |
dc.description.citedreference | CROCKSON RA, 1966, CLIN CHIM ACTA, V14, P435 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.